Table 2.

Demographics and Clinical Parameters of COVID-19-Infected Patients

Parameters	All Cases (n=43)	No ICU Visit (n=38)	With ICU Visit (n=5)	P–value
Demographic and clinical
Age (years)	5.8 (0.04–13.3)	5.9 (0.06–13.32)	1.4 (0.04–7.12)	0.04
Gender (female/male)	24/19	20/18 (52.6%)	4/1 (80.0%)	0.363
BMI	15.7±2.9	15.8±2.9	15.0±2.8	0.58
Comorbidities (positive/negative)	26/17 (60.5%)	22/16 (57.9%)	4/1 (80.0%)	0.633
Hypertension	2/41 (4.7%)	0/38 (0%)	2/3 (40.0%)	0.011
Diabetes	1/42 (2.3%)	1/37 (2.6%)	0/5 (0%)	1.000
Bleeding	0/43 (0%)	0/38 (0%)	0/5 (0%)	–
Previous VTE	0/43 (0%)	0/38 (0%)	0/5 (0%)	–
Malignancy	9/34 (20.9%)	8/30 (21.1%)	1/4 (20.0%)	1.000
Hyperlipidemia	1/42 (2.3%)	1/37 (2.6%)	0/5 (0%)	1.000
Stem Cell Transplantation	6/37 (14.0%)	4/34 (10.5%)	2/3 (40%)	0.135
Symptoms (positive/negative)	27/16 (62.8%)	23/15 (60.5%)	4/1 (80.0%)	0.635
Fever	23/20 (53.5%)	19/19 (50.0%)	4/1 (80.0%)	0.351
Respiratory	5/38 (11.6%)	2/36 (5.3%)	3/2 (60.0%)	0.008
GIT related	3/40 (7.0%)	3/35 (7.9%)	0/5 (0%)	1.000
COVID-19 Stage				0.072
Stage A	14 (32.6%)	14 (36.8%)	0 (0%)
Stage B	27 (62.8%)	23 (60.5%)	4 (80%)
Stage C	1 (2.3%)	0 (0%)	1 (20%)
Stage D	1 (2.3%)	1 (2.6%)	0 (0%)
Stage E	0 (0%)	0 (0%)	0 (0%)
ABO groups (n=41)				0.049
A	13 (31.7%)	9 (25.0%)	4 (80.0%)
AB	2 (4.9%)	2 (5.6%)	0 (0%)
B	8 (19.5%)	7 (19.4%)	1 (20.0%)
O	18 (43.9%)	18 (50.0%)	0 (0%)

Notes: The variable BMI was normally distributed while age followed a non-normal distribution. Data are presented as mean±standard deviation for normally distributed and median (minimum-maximum) for non-normally distributed variable.

Abbreviations: GIT, gastrointestinal tract; DIC, disseminated intravascular coagulopathy; INR, international normalized ratio; PT, prothrombin time; HCT, hematopoietic cell transplant.